Table 1.
Patients (n = 56) | Controls (n = 40) | p | |
---|---|---|---|
Age (years) | 67.5 ± 12.6 | 64.6 ± 8.5 | 0.20** |
Sex (male, n) | 32 | 24 | 0.780* |
AF (n) | 33 | 0 | < 0.001* |
DM (n) | 28 | 6 | < 0.001* |
HT (n) | 49 | 19 | < 0.001* |
HL (n) | 18 | 3 | 0.004* |
EF (%) | 40.8 ± 12.8 | 65.4 ± 4.9 | < 0.001 |
LVEDD (mm) | 55.0 ± 14.5 | 46.0 ± 3.2 | < 0.001 |
LVESD (mm) | 43.9 ± 15.4 | 29.0 ± 3.1 | < 0.001 |
LAA (cm2) | 25.6 ± 10.1 | 15.5 ± 2.2 | < 0.001 |
Data are presented as mean ± standard deviation or number of patients. AF: Atrial fibrillation; DM: Diabetes Mellitus; HT: Hypertension; HL: Hyperlipidemia; EF: Ejection fraction; LVEDD: Left ventricle end-diastolic diameter; LVESD: Left ventricle end-systolic diameter; LAA: Left atrial area.
Chi-square test was used,
Student t test was used, others were evaluated with Mann-Whitney U test.